Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. Patients with HHT may have telangiectasias and later may develop arteriovenous malformations in various organs. Pacients suffer from m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vnitřní lékar̆stvĭ 2021, Vol.67 (6), p.339-344
Hauptverfasser: Adam, Zdeněk, Brančiková, Dagmar, Romanová, Gabriela, Pour, Luděk, Krejčí, Marta, König, Jiří, Nebeský, Tomáš, Adamová, Zuzana, Štork, Martin, Krejčí, Martin, Ševčíková, Sabina, Eid, Michal, Král, Zdeněk
Format: Artikel
Sprache:cze
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. Patients with HHT may have telangiectasias and later may develop arteriovenous malformations in various organs. Pacients suffer from many complications caused by the malformations and therefore by patients with HHT must by performed screening of this arteriovenous malformations. Optimal treatment of this malformations is best delivered throught a multidisciplinary approach. Farmacological treatment is described in next paper.
ISSN:0042-773X
1801-7592
DOI:10.36290/vnl.2021.090